Other OTC • Healthcare • Medical - Instruments & Supplies • FR • USD
Sartorius Stedim Biotech S.A. (SRTOY) has a consensus analyst rating of Hold, based on 1 analyst covering the stock. Of those, 0 recommend buying, 1 recommend holding, and 0 recommend selling.
No price target data available.
Be the first to know when stocks drop below their intrinsic value.